e-learning
resources
Vienna 2009
Sunday, 13.09.2009
One size (does not) fit all: phenotyping and controlling asthma
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Oral steroid intervention in severe asthma: focus on phenotypes. Report from the bioair study
R. Middelveld, M. Kupczyk, S. E. Dahlén, BIOAIR (Stockholm, Sweden)
Source:
Annual Congress 2009 - One size (does not) fit all: phenotyping and controlling asthma
Session:
One size (does not) fit all: phenotyping and controlling asthma
Session type:
Oral Presentation
Number:
375
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
R. Middelveld, M. Kupczyk, S. E. Dahlén, BIOAIR (Stockholm, Sweden). Oral steroid intervention in severe asthma: focus on phenotypes. Report from the bioair study. Eur Respir J 2009; 34: Suppl. 53, 375
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Consequences of long-term oral corticosteroid therapy and its side-effects in severe asthma in adults: a focused review of the impact data in the literature
Source: Eur Respir J, 52 (4) 1800703; 10.1183/13993003.00703-2018
Year: 2018
4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016
Prognosis of new-onset asthma diagnosed at adult age: A systematic review
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Adherence and effectiveness of omalizumab treatment in severe allergic asthma patients: Do the patients like injectable treatment?
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013
Effect of 1 year treatment with inhaled corticosteroids with electronically assessed adherence on height growth in children with asthma
Source: International Congress 2015 – Paediatric asthma and allergy: asthma management
Year: 2015
Study to evaluate clinical burden related with oral corticosteroids treatment of severe asthma in Spain (LEVANTE)
Source: Virtual Congress 2020 – Advances in asthma treatment
Year: 2020
Treatment of severe childhood asthma: what’s the evidence?
Source: Annual Congress 2005 - Difficult asthma in children
Year: 2005
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function
Source: Annual Congress 2013 –Uncontrolled and severe asthma in children
Year: 2013
Evaluating the effects of asthma therapy on childhood growth: what can be learnt from the published literature?
Source: Eur Respir J 2002; 19: 1179-1193
Year: 2002
Effectiveness of montelukast on asthma control in infants: A claims data study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Work related symptoms of adult patients with asthma: A multicenter, national, questionnaire based study
Source: International Congress 2015 – Work, environment and the epidemiology of asthma
Year: 2015
Management of occupational asthma: cessation or reduction of exposure? A systematic review of available evidence
Source: Eur Respir J 2011; 38: 804-811
Year: 2011
Effect of not appropriate treatment in severe/not controlled asthma: The AGAVE study
Source: International Congress 2015 – Treatment and control of respiratory disease
Year: 2015
Evaluating the effects of asthma therapy on childhood growth: principles of study design
Source: Eur Respir J 2002; 19: 1167-1178
Year: 2002
X-Tab: Non-interventional study to assess patient-related mid-term outcomes of omalizumab therapy in severe allergic asthmatic patients
Source: International Congress 2016 – Phenotyping and monitoring airway diseases
Year: 2016
Medication use in children with asthma: a case control study
Source: Eur Respir J 2001; 18: Suppl. 33, 329s
Year: 2001
Mepolizumab in a population with severe eosinophilic asthma and corticosteroid dependence: results from a French early access programme
Source: Eur Respir J, 55 (6) 1902345; 10.1183/13993003.02345-2019
Year: 2020
A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013
APEXII- A prospective study investigating the efficacy of omalizumab treatment in severe allergic asthma
Source: International Congress 2015 – Immune aspects of asthma and other airway diseases
Year: 2015
Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis
Source: International Congress 2014 – Intervening in allergic asthma
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept